These positive advances in the form of less potent anticholinergic drugs may contribute to reduced awareness among clinicians of possible adverse effects. This places the elderly at risk of ...

Clinical monitoring of anticholinergic adverse effects is limited to the use of clinical instruments that classify drugs categorically according to their degree of anticholinergicity. Moreover ...

Dr James Pickett, Head of Research at Alzheimer’s Society, warned commonly-prescribed drugs that treat conditions including ...

A recent scientific study has issued warnings that certain commonly prescribed medications could elevate the risk of dementia ...